• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Merit Medical to pay $167M for GE Healthcare’s Thomas Medical OEM vascular access biz

Merit Medical to pay $167M for GE Healthcare’s Thomas Medical OEM vascular access biz

November 27, 2012 By MassDevice staff

Merit Medical Systems

Merit Medical Systems (NSDQ:MMSI) agreed to pony up some $167 million for GE Healthcare‘s (NYSE:GE) Thomas Medical Products business, which makes an OEM maker of catheters used for vascular access.

South Jordan, Utah-based Merit Medical said the deal, expected to close before the end of the year, could boost its sales to $420 million on a pro forma basis, with Malvern, Pa.-based Thomas Medical contributing $37 million.

The merger is also expected to boost Merit Medical’s gross margin by 80 basis points, putting an extra $4.2 million a year in cash into the medical device company’s coffers, according to a regulatory filing. During 2013 and 2014 the acquisition is forecast to add 3¢ to earnings per share; adjusted to exclude 1-time items, EPS are expected to reach 15¢ in 2013 and 13¢ in 2014, according to the filing. Merit also said it expects the deal to enable a tax break worth about $43 million of net present value.

Founded in 1990, Thomas Medical was acquired by GE Healthcare in 2008, according to its website.

Merit said it plans to fund the deal by increasing its credit facility with Wells Fargo Bank to $275 million.

"We believe this transaction will help expand our market presence into new product categories, particularly in interventional cardiology," Merit chairman & CEO Fred Lampropoulo said in prepared remarks. "A majority of cardiac rhythm access procedures utilize products of the nature manufactured by Thomas Medical. We believe substantial international expansion opportunities exist, especially in China, Japan, Russia and the Gulf States, as well as significant new product development opportunities based on know-how and existing intellectual property."

GE Healthcare Systems CEO Tom Gentile said the divestiture "will provide Thomas Medical new capabilities to maximize its opportunities in the single-use vascular access product space and enable GE Healthcare’s cardiovascular segment to remain focused on its core strengths as a provider of total integrated cardiology lab solutions. In addition, we believe Merit Medical will bring a huge amount of expertise in these segments to take Thomas Medical to the next level."

Filed Under: Mergers & Acquisitions, News Well, Vascular, Wall Street Beat Tagged With: GE Healthcare, Merit Medical Systems, Thomas Medical Products

More recent news

  • Imperative Care has positive stroke treatment study results
  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • Intuitive demonstrates remote telesurgery capabilities with da Vinci 5
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • CVRx announces Medicare win for Barostim therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy